Awakn Life Sciences CEO Details ‘Groundbreaking’ MDMA Discovery in Quest to Treat Addiction
Business, Research, TreatmentAnthony Tennyson tells the Psychedelic Spotlight Podcast that his company has "discovered receptor sites that MDMA interacts with that we believe nobody else in the world knows about."
Wesana Health to Acquire Psychedelic Therapy and Software Company PsyTech
Business, Research, TreatmentThe deal creates Wesana Clinics, a chain of mental health facilities focused on delivering psychedelic-assisted psychiatric care, as well as data platform Wesana Solutions.
Why Psychedelics Could Eventually Treat Asthma
Research, TreatmentResearchers continue to explore anti-inflammatory nature of psychedelics, which in small doses, may alleviate asthma symptoms.
Psychedelic Biotech Company Cybin Partners with Greenbrook to Develop Innovative Depression Treatment
Business, Research, TreatmentCybin CEO says agreement "serves as a major step toward establishing a national distribution network for future psychedelic therapies."
Numinus Wellness to Acquire Neurology Centre of Toronto to Create Psychedelic Treatment Facility
Business, TreatmentNCT will utilize Numinus' expertise in psychedelic-assisted therapy to create a specialization in the application of psychedelics in the field of neurology
How to Become a Psychedelic Facilitator
Education, TreatmentAs psychedelic medicine gains momentum, a growing number of organizations are offering psychedelic facilitator programs. Here's how to become one.
First-Of-Its-Kind Ketamine Prescribing Service Now Available to Psychotherapists
TreatmentA new first-of-its-kind ketamine prescribing service comes to independent psychotherapists using the dissociative with their patients.
Imperial College and Heroic Hearts Launch Psychedelic Research Retreat for Veterans with Head Trauma
Research, TreatmentA new veterans research-focused psychedelic retreat in partnership between Heroic Hearts and Imperial College looks at treating brain injuries.
Psychedelic Educational Platform Launches Integration Therapy Survey Study to Promote Harm Reduction
Research, TreatmentA new platform is aimed at psychedelic experience integration and harm reduction by surveying practitioners and patients.
Extended-Release Ketamine Effective in Patients With Treatment-Resistant Depression
TreatmentKetamine may offer new hope for sufferers of treatment resistant depression via an extended-release oral administered option.